DSS 📈 DSS - Overview

Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock • ISIN: US26253C1027

DSS: Packaging, Biotech, Finance, Securities, Lending, Healthcare

DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, alternative trading, and direct marketing businesses. It manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, it focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engages in nonbanking activities related to banking, such as loan syndication, mortgage banking, trust and escrow, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services; and operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as operates as a digital assets broker dealer. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York. Web URL: https://www.dssworld.com

Additional Sources for DSS Stock

DSS Stock Overview

Market Cap in USD 6m
Sector Consumer Cyclical
Industry Packaging & Containers
GiC Sub-Industry Commercial Printing
IPO / Inception 1997-01-03

DSS Stock Ratings

Growth 5y -98.8%
Fundamental -52.4%
Dividend -
Rel. Strength Industry -417
Analysts 5/5
Fair Price Momentum 0.28 USD
Fair Price DCF -

DSS Dividends

No Dividends Paid

DSS Growth Ratios

Growth Correlation 3m -76.1%
Growth Correlation 12m -94.8%
Growth Correlation 5y -98.4%
CAGR 5y -65.11%
CAGR/Mean DD 5y -0.80
Sharpe Ratio 12m -1.47
Alpha -75.89
Beta 0.16
Volatility 83.46%
Current Volume 74.6k
Average Volume 20d 68.4k
What is the price of DSS stocks?
As of December 22, 2024, the stock is trading at USD 0.83 with a total of 74,602 shares traded.
Over the past week, the price has changed by -19.60%, over one month by -20.38%, over three months by -33.22% and over the past year by -67.42%.
Is DSS a good stock to buy?
No, based on ValueRay Fundamental Analyses, DSS (NYSE MKT:DSS) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -52.38 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DSS as of December 2024 is 0.28. This means that DSS is currently overvalued and has a potential downside of -66.27%.
Is DSS a buy, sell or hold?
DSS has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy DSS.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for DSS stock price target?
According to ValueRays Forecast Model, DSS DSS will be worth about 0.3 in December 2025. The stock is currently trading at 0.83. This means that the stock has a potential downside of -63.86%.
Issuer Forecast Upside
Wallstreet Target Price 27.6 3225.3%
Analysts Target Price 1.5 80.7%
ValueRay Target Price 0.3 -63.9%